Apr 21, 2022
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time. The company plans to...
- Apr 7, 2022
DaVita Inc. announced today that its board of directors appointed a new independent director, Jason M. Hollar, to join the board, effective May 6, 2022. Mr. Hollar brings more than 25 years of...
Apr 4, 2022New Research Affirms Increase in Access, Equity of COVID-19 Vaccines Administered in Dialysis Centers
Results demonstrate the importance of vaccinating patients at trusted sites of care DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ -- A federal partnership established to help increase...
Feb 17, 2022DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney PatientsResearch further demonstrates COVID-19 vaccination as an important clinical strategy to help protect vulnerable patients from infection
Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis...
Feb 16, 2022Dr. Mihran Naljayan will take the clinical leadership role for DaVita
DaVita Kidney Care today announced Dr. Mihran Naljayan as chief medical officer (CMO) of Home Modalities. Dr. Naljayan joined DaVita in 2016 and most recently served as vice president of clinical...